Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	116.06	126.60	58.60
Graham Fair Price	-62.33	7.11	18.86
PEG	3693.80	1.06	0.03
Price/Book	-12.55	1.76	2.01
Price/Cash Flow	74.72	-25.88	-102.37
Prices/Earnings	514.81	-122.15	19.87
Price/Sales	6.26	14.63	13.77
Price/FCF	74.72	-25.88	-102.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-10.36	0.41	0.46
Operating Margin	-66.23	-0.06	0.17
ROA	-85.81	< 0.005	0.01
ROE	0.03	< 0.005	-85.78
ROIC	0.02	< 0.005	-60.21
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	< 0.005	688.55
Dividends QOQ	< 0.005	< 0.005	0.85
EBIT QOQ	324.13	-1.28	-99.61
EPS QOQ	7.14	-1.16	-83.79
FCF QOQ	-30.18	-2.47	91.81
Revenue QOQ	0.09	-0.17	97.50
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	119.80	137.80	15.02
Days Sales Outstanding (DSO)	19.87	23.50	18.27
Inventory Turnover	0.75	0.65	-13.06
Debt/Capitalization	0.32	0.33	4.05
Quick Ratio	1.01	0.91	-10.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.01	24.98	-0.11
Cash	5.93	5.02	-15.27
Capex	-1.59	-1.41	11.26
Free Cash Flow	-0.49	-1.70	-245.52
Revenue	3.65	3.00	-17.80
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.54	1.57	1.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.72	24.88	155.86
Naive Interpretation	Member

06 - Financial Health · Weak

Rating